Meet the Organizers
To better build on the values and opportunities inherent in the medical device community, this year Medtech Strategist’s Innovation Summit San Francisco is joining with four of the leading players in the industry - Fogarty Institute for Innovation, Lightstone Ventures, New Enterprise Associates, and Wilson, Sonsini, Goodrich & Rosati - to create a new kind of conference.
MedTech Strategist is a global information provider and Subject Matter Experts focused exclusively on the under-served medtech market. With more than 100 years of combined experience, we have worked together for nearly two decades, providing medical device industry executives with both breadth and depth in our industry publications, MedTech Strategist and MedTech Strategist Market Pathways, and providing our community with access to unparalleled connections at our medical device conferences.
New Enterprise Associates, Inc. (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. With more than $20 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 225 portfolio company IPOs and more than 375 acquisitions.
At the Fogarty Institute, we believe innovation is the lifeblood of medical advancement. This conviction drives our seasoned team as we seek unique pathways to bring life-changing medical therapies to market faster. Dr. Thomas J. Fogarty, one of the most noted cardiovascular surgeons and innovators of all time, founded the Institute with the vision of improving patients’ lives while lowering healthcare costs. As an educational nonprofit, we are uniquely positioned to expand on this goal through our programs that cultivate innovators, accelerate the development of their ideas and elevate the global medtech ecosystem.
Wilson Sonsini Goodrich & Rosati is the premier provider of legal services to life sciences, technology, and growth enterprises worldwide. The firm is nationally recognized as a leader in corporate governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, joint ventures and strategic alliances, and technology licensing and other intellectual property transactions.
Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space. With strategic insight and a proven strategy, we are well-positioned to continue to find unique investments and drive life science innovation for patients. Members of the Lightstone team manage a portfolio of more than 40 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds